Effects of liraglutide on abdominal fat distribution and glucose metabolism in Chinese subjects with obesity
LFC was significantly reduced after liraglutide monotherapy for 12 weeks in subjects with obesity. The LFC reduction is likely to be associated with IGR remission in obese subjects.
Authors
- Qing Lü (ORCID: https://orcid.org/0000-0001-5350-776X)
- Shengyun He
- Jiang Yue (ORCID: https://orcid.org/0000-0001-8906-1253)
- Lihua Wang (ORCID: https://orcid.org/0000-0001-5069-7772)
- Xiaobing Lu (ORCID: https://orcid.org/0009-0000-7339-8679)
- Jing Ma (ORCID: https://orcid.org/0000-0003-1098-945X)
- Minglan Yang
- Yicheng Qi
- Mengyang Du
Institutions
- Shanghai Jiao Tong University (CN)
- Renji Hospital (CN)
Publication Details
- Journal
- Diabetology & Metabolic Syndrome
- Published
- 2024-12-20
- DOI
- https://doi.org/10.1186/s13098-024-01540-4
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- China International Medical Foundation